Premium
Lupin Ltd, India's second largest drugmaker by market value, had been pursuing inorganic expansion during 2007-11, but had gone quiet on the mergers and acquisitions (M&A) front since then. Early last year, it revived its M&A-led growth strategy and since then has signed half a dozen deals. In July, it ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
